SEC Form 4 · accession 0001209191-15-079334
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald W Barrett
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2015 | M | 17,699 | $1.13 | A | 17,699 | D | |
| Common Stock | Nov 9, 2015 | S | 7,699 | $22.75 | D | 10,000 | D | |
| Common Stock | Nov 9, 2015 | S | 10,000 | $21.90 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (right to buy)F1 | $1.13 | Nov 9, 2015 | M | 17,699 | D | — | Dec 11, 2017 | Common Stock | 17,699 | 0 | D |
Explanation of responses
- F1Immediately.